HK1140547A1 - Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combination with nt-probnp ct-proet-1 nt-probnp - Google Patents

Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combination with nt-probnp ct-proet-1 nt-probnp

Info

Publication number
HK1140547A1
HK1140547A1 HK10106771.0A HK10106771A HK1140547A1 HK 1140547 A1 HK1140547 A1 HK 1140547A1 HK 10106771 A HK10106771 A HK 10106771A HK 1140547 A1 HK1140547 A1 HK 1140547A1
Authority
HK
Hong Kong
Prior art keywords
proet
probnp
diagnosis
combination
acute coronary
Prior art date
Application number
HK10106771.0A
Other languages
English (en)
Chinese (zh)
Inventor
‧博格曼
‧莫根塔勒
‧帕帕索提裡奧
‧斯塔克
‧恩格
Original Assignee
布拉姆斯有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 布拉姆斯有限公司 filed Critical 布拉姆斯有限公司
Publication of HK1140547A1 publication Critical patent/HK1140547A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HK10106771.0A 2006-12-22 2010-07-13 Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combination with nt-probnp ct-proet-1 nt-probnp HK1140547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006060835A DE102006060835A1 (de) 2006-12-22 2006-12-22 Diagnose und Risikostratifizierung des akuten Koronarsyndroms mittels CT-proET-1 in Kombination mit NT-proBNP
PCT/DE2007/002313 WO2008077396A1 (de) 2006-12-22 2007-12-22 Diagnose und risikostratifizierung des akuten koronarsyndroms mittels ct-proet-1 in kombination mit nt-probnp

Publications (1)

Publication Number Publication Date
HK1140547A1 true HK1140547A1 (en) 2010-10-15

Family

ID=39410311

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10106771.0A HK1140547A1 (en) 2006-12-22 2010-07-13 Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combination with nt-probnp ct-proet-1 nt-probnp

Country Status (8)

Country Link
US (1) US8524463B2 (xx)
EP (1) EP2122365B1 (xx)
JP (1) JP5190067B2 (xx)
CN (1) CN101646945B (xx)
DE (1) DE102006060835A1 (xx)
ES (1) ES2399931T3 (xx)
HK (1) HK1140547A1 (xx)
WO (1) WO2008077396A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906857B2 (en) * 2005-12-01 2014-12-09 B.R.A.H.M.S. Gmbh Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
JP5308328B2 (ja) 2006-04-04 2013-10-09 シングレックス，インコーポレイテッド トロポニンの分析のための高感度のシステムおよび方法
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
DE102007021443A1 (de) * 2007-05-08 2008-11-13 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels NT-proET-1
CN102428368B (zh) * 2009-05-05 2015-04-22 B.R.A.H.M.S有限公司 患有内皮功能/功能障碍相关疾病的患者的基于血管活性激素的分层
JP5678045B2 (ja) 2009-06-08 2015-02-25 シンギュレックス・インコーポレイテッド 高感度バイオマーカーパネル
US20120321595A1 (en) 2009-11-09 2012-12-20 The Brigham And Women's Hospital, Inc. Treatment of heart disease
EP2737320B1 (en) 2011-07-28 2016-08-24 B.R.A.H.M.S GmbH MID-REGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE (MR-proANP) FOR THE IDENTIFICATION OF PATIENTS WITH ATRIAL FIBRILLATION WITH AN ONSET OF LESS THAN 48 HOURS AGO
WO2014116708A1 (en) * 2013-01-22 2014-07-31 Singulex, Inc. Endothelin in the diagnosis of cardiac disease
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144062A0 (en) * 1999-01-29 2002-04-21 Roche Diagnostics Gmbh METHOD OF IDENTIFYING N-TERMINAL proBNP
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
MXPA03004105A (es) 2002-05-14 2004-10-15 Hoffmann La Roche Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores.
GB0227179D0 (en) * 2002-11-21 2002-12-24 Univ Leicester Bodily fluid markers of tissue hypoxia
CA2507415A1 (en) 2002-11-21 2004-06-03 The University Of Leicester Bodily fluid markers of tissue hypoxia
DE10351238A1 (de) * 2003-11-03 2005-06-02 Roche Diagnostics Gmbh Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern
EP1564558B1 (de) * 2004-02-13 2005-12-07 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Bestimmung der Bildung von Endothelinen zu Zwecken der medizinischen Diagnostik, sowie Antikörper und Kits für die Durchführung eines solchen Verfahrens
ES2300681T3 (es) 2004-07-22 2008-06-16 Brahms Aktiengesellschaft Procedimiento para el diagnostico y tratamiento de pacientes criticos con endotelina, agonistas de endotelina y antagonistas de adrenomedulina.

Also Published As

Publication number Publication date
WO2008077396A1 (de) 2008-07-03
CN101646945A (zh) 2010-02-10
US20100151504A1 (en) 2010-06-17
JP2010513880A (ja) 2010-04-30
US8524463B2 (en) 2013-09-03
EP2122365A1 (de) 2009-11-25
DE102006060835A1 (de) 2008-06-26
CN101646945B (zh) 2014-06-04
JP5190067B2 (ja) 2013-04-24
ES2399931T3 (es) 2013-04-04
EP2122365B1 (de) 2012-12-19

Similar Documents

Publication Publication Date Title
HK1140547A1 (en) Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combination with nt-probnp ct-proet-1 nt-probnp
IL234345A (en) Systems and methods for using planning information together with test information
TWI561237B (en) Substituted dihydropyrazolones and their use
EP2079489A4 (en) ABSORBENT ARTICLE WITH ABSORPTION STRUCTURE
BRPI1006441A2 (pt) estrutura compósita com uma superfície e estrutura compósita sobremoldada
EP2010028A4 (en) FURNITURE FOR SITTING WITH LIFTING MECHANISM
EP2236604A4 (en) ANTI-NR10 ANTIBODIES AND USE THEREOF
EP2376593A4 (en) PHOTO-ACTIVE COMPOSITION AND ELECTRONIC DEVICE USING THE COMPOSITION
EP2006305A4 (en) MODIFIED ANTIBODIES WITH IMPROVED BIOLOGICAL ACTIVITY
IL205713A0 (en) Afucosylated antibodies against ccr5 and their use
EP2376595A4 (en) PHOTOACTIVE COMPOSITION AND ELECTRONIC DEVICE MADE WITH THE SAME
HK1173973A1 (en) Antibody therapeutics with local activity in the digestive tract
HK1150061A1 (en) Antibody and use thereof
HK1120013A1 (en) Elevator with two superimposed cars in one shaft
EP1984862A4 (en) PLASTIC TOMOGRAPHY
EP2118304A4 (en) HOMOGENEOUS IN VITRO-FEC TEST PROCEDURES AND COMPONENTS
SI2165935T1 (sl) Zapiralnik s pregledovalno enoto
EP2209903A4 (en) PROMOTER DETECTION AND ANALYSIS
EP2047263A4 (en) COMPOSITIONS AND METHODS OF DIAGNOSIS IN PATIENTS WITH ACUTE ATHEROSCLEROTIC SYNDROME
IL207647A0 (en) Use of interleukin-1 conjugates in the treatment of diabetes
EP2321320A4 (en) NEW COMPOUNDS AND THEIR USES IN DIAGNOSIS
GB0723638D0 (en) Apparatus for accurate ambient noise sensing and reduction in the presence of wind
EP1872126A4 (en) CD39L3 AND ITS ROLE IN DIABETES
HK1156056A1 (zh) 經修飾的抗-肝素/ 複合物抗體以及 抗體標準
EP2451466A4 (en) APOLIPOPROTEIN CIII IN PRE DIABETES AND TYPE 2 DIABETES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191221